Get the latest news on SSY Group stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on LJUIF performance

Latest SSY Group Stock News | OTC:LJUIF | Benzinga

SSY Group Ltd is engaged in the research, development, manufacturing and selling of a wide range of pharmaceutical products, which includes finished medicines of mainly intravenous infusion solution and ampoule injection to hospitals and distributors, bulk pharmaceuticals and medical materials. The company has two reportable segments including intravenous infusion solution and others and medical materials. The company derives a vast majority of its revenue principally from the Intravenous infusion solution and others. Revenue generation is driven mostly by its sales of pharmaceutical products, followed by medical materials.

News

Intraday Update

Markets

Movers

Trading Ideas

AAON

ADYYF

AIQUY

ALPMY

AMZN

APLT

APPF

APTO

ATBPF

BXMT

CHDN

CHTR

CLHRF

CNNE

CPRT

CPSH

CRMT

CVCO

CWST

DECK

DOCU

DXCM

EDPFY

ELVT

EPRT

FATE

Flaherty Crumrine/Claymore Preferred Securities

FJTSY

FLEX

FORTY

FTMNF

GLDLF

GLPI

GLVMF

HNNMY

INVH

ITCC

ITMR

KDDIY

LBRDA

LBRDK

LJUIF

LLIT

MCBI

MCRI

MDLZ

MGEE

MGRUF

Blackrock Muniholdings New York Quality Fund

MKTAY

MLKKF

MSCI

Blackrock Muniholdings California Quality Fund

NDAQ

Nuveen Insured Tax-Free Advantage Municipal Fund

Nuveenn Intermediate Duration Quality Municipal Term Fund Common Shares of Beneficial Interest

Nuveen Georgia Dividend Advantage Municipal Funds 2

Nuveen Insured California Tax-Free Advantage Municipal Fund

Nuveen Municipal High Income Opportunity Fund

Stocks That Hit 52-Week Highs On Friday

SSY Group Ltd

SSY Group

Comments

SSY Group Stock News

News

Latest SSY Group Stock News | OTC:LJUIF | Benzinga

Friday, January 31, 2020

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga